Disproportionality in reporting herpes zoster infection was higher for patients receiving fingolimod compared with those receiving other disease-modifying treatments ( empirical Bayes geometric mean , @ -LSB- @ % CI , @-@ @ -RSB- ) ; the proportion of serious herpes zoster infections was not higher than the proportion for other treatments ( empirical Bayes geometric mean , @ -LSB- @ % CI , @-@ @ -RSB- ) .